Sodium cromoglycate (cromolyn sodium). II. Allergic rhinitis and other conditions.
D000281:Administration, Intranasal; D000328:Adult; D000336:Aerosols; D002648:Child; D002986:Clinical Trials as Topic; D003231:Conjunctivitis / Q000188:drug therapy; D004205:Cromolyn Sodium / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004341:Drug Evaluation; D004347:Drug Interactions; D005128:Eye Diseases / Q000188:drug therapy; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D008286:Malabsorption Syndromes / Q000188:drug therapy; D008894:Milk Proteins / Q000378:metabolism; D009297:Nasal Mucosa / Q000187:drug effects; D010919:Placebos; D012119:Respiration / Q000187:drug effects; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D012882:Skin Tests; D012996:Solutions; D013997:Time Factors
D000336:Aerosols; D006634:Histamine H1 Antagonists; D008894:Milk Proteins; D010919:Placebos; D012996:Solutions; D004205:Cromolyn Sodium